Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Clinical Utility of Point of Care Cobas® Liat CT/NG/MG Nucleic Acid Test Versus Current Standard Practice

NCT06369220 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT06369220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06369220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Clinical Utility of Point of Care Cobas® Liat CT/NG/MG Nucleic Acid Test Versus Current Standard Practice
Lead sponsor
Hoffmann-La Roche
Phase
Not applicable
Overall status
Completed
Start date
July 29, 2024
Completion date
May 28, 2025
Enrollment
331 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis infection, mycoplasma genitalium infection, neisseria gonorrhoeae infection